1094 (1094) Fair Value & Analysis

Industrials · Market cap HK$151M

1 1094 1094 · HK

PriceHK$0.2550

Fair ValueHK$0.2000

Upside-21.6%

Quality27/100

Evidence: Low Range HK$0.1500 – HK$0.3000

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −23.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2550 – HK$0.9000 · fair‑value band HK$0.1500 – HK$0.3000 · the HK$0.2550 price screens above the HK$0.2000 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1094 (1094) currently trades at HK$0.2550, while our model-based Fair Value estimate is HK$0.2000 — implying the stock looks roughly 21.6% overvalued today. We read business quality at 27/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1094 generated revenue of HK$46.9M at a net margin of -61.1%. Revenue declined 14.0% year over year. It earns a return on equity of -16.0%. Net debt stands at HK$169M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$46.9M

Revenue growth (YoY) -14.0%

Net margin -61.1%

Return on equity -16.0%

Free cash flow −HK$13.3M FY2025

Operating margin -26.5%

More key figures

EPS (TTM) HK$-0.2800

EPS growth (YoY) -18.5%

Net debt HK$169M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1094 reported revenue of HK$46.9M in FY2025 versus HK$112M in FY2021, a compound −19.6%/yr. Reported net income was −HK$28.7M in FY2025.

Revenue −19.6%/yr

FY21 HK$112M

FY22 HK$272M

FY23 HK$782M

FY24 HK$98.3M

FY25 HK$46.9M

Net income

FY21 −HK$25.5M

FY22 HK$13.3M

FY23 HK$656K

FY24 −HK$124M

FY25 −HK$28.7M

Is 1094 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Honeywell International Inc HON	C$25.91	C$16.17	-38%
Hitachi, Ltd HTHIY	$29.38	$23.57	-20%
CITIC Limited 0267	HK$12.30	HK$37.22	+203%
0019 0019	HK$81.70	HK$13.77	-83%
CK Hutchison Holdings 0001	HK$68.20	HK$146.23	+114%
Itaúsa S.A ITSA3	R$13.05	R$13.52	+4%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1094 (1094) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.2000 versus a price of HK$0.2550 — about −22% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1094?

Our model-based fair value for 1094 is HK$0.2000 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2550.

What is the quality score of 1094?

1094 has a Quality Score of 27/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1094 (1094)?

1094 reported trailing-twelve-month revenue of about HK$46.9M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1094?

The net profit margin of 1094 is about -61.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.